Under Rs 2060 Stocks to Buy in November 2026: 5 Names on the Watchlist

The under Rs 2060 stocks to buy in November 2026 start with five listed names: Avalon Technologies, Bajaj Finserv, Cholamandalam Investment and Finance, Coforge and Sun Pharmaceutical Industries. Stocks under Rs 2,060 include an electronics maker, a financial services group, a vehicle finance company, an IT services company and India's largest pharma company, priced from about Rs 1,815 to Rs 2,040. Bajaj Finserv and Sun Pharmaceutical Industries are part of the Nifty 50 index, Bajaj Finserv is part of the Nifty Fin Service index, Coforge is part of the Nifty IT index and Sun Pharmaceutical Industries is part of the Nifty Pharma index.

This article ranks none of them as a sure thing. It lays out the numbers each company has reported, how the shares are priced today and what an investor should check before adding any of these under Rs 2060 stocks to buy to a portfolio. All prices are NSE closing prices of 11 November 2026, and financials come from company filings.

Click Here – Get Free Investment Predictions

Which Are the Best Under Rs 2060 Stocks to Buy in November 2026?

The best under Rs 2060 stocks to buy in November 2026 for a watchlist are Avalon Technologies, Bajaj Finserv, Cholamandalam Investment and Finance, Coforge and Sun Pharmaceutical Industries. They were picked because each has complete reported financials, profit in the latest quarter and an NSE listing. The table puts their market data side by side.

Company	CMP (Rs)	Market Cap	P/E	ROE	Dividend Yield
Avalon Technologies	2,040	Rs 13,719 crore	102.66	15.65%	0.00%
Bajaj Finserv	1,845	Rs 2,65,782 crore	12.88	12.58%	0.09%
Cholamandalam Investment and Finance	1,815	Rs 1,37,140 crore	22.04	18.02%	0.12%
Coforge	2,018	Rs 86,836 crore	41.36	9.80%	0.61%
Sun Pharmaceutical Industries	1,902	Rs 4,22,991 crore	34.91	13.74%	0.91%

On valuation, Bajaj Finserv trades below the industry P/E; Sun Pharmaceutical Industries sits close to it; Avalon Technologies, Cholamandalam Investment and Finance and Coforge carry a premium. Valuation is the first filter for any under Rs 2060 stocks to buy list, and it is covered again in the risk section.

Why These Under Rs 2060 Stocks to Buy Are in Focus

A higher share price does not mean a stock is expensive, because value depends on earnings and the number of shares. The list covers an electronics manufacturing company, a diversified financial services group, a vehicle finance company, a mid sized IT services company and the country's largest pharma company, all of which closed below Rs 2,060 on the NSE on 11 November. Investors searching for the best stocks under Rs 2,060 in India should check earnings, valuation and debt.

Avalon Technologies: The Export-Led EMS Name Among Under Rs 2060 Stocks to Buy

Avalon Technologies is an electronics manufacturing services company for industrial, clean energy, mobility and medical clients. The stock trades at Rs 2,040 with a market capitalisation of Rs 13,719 crore and a P/E of 102.66, against an industry P/E of 41.86.

FY26 revenue rose 46.3% to Rs 1,632 crore and net profit rose 78.0% to Rs 113 crore. In the June 2026 quarter, revenue grew 49.9% year on year to Rs 487 crore, while net profit grew 145.4% to Rs 34.9 crore.

Return on equity is 15.65%, debt-to-equity is 0.29, and the dividend yield is negligible. Promoters hold 40.35%, foreign institutions 11.13% and domestic institutions 19.96% as of September 2026. Foreign institutional holding has risen from 10.04% to 11.13% over the last year. A point to keep in view: at a P/E of 102.66, expectations are already high.

Bajaj Finserv: The Lending and Insurance Holding Company Among Under Rs 2060 Stocks to Buy

Bajaj Finserv is the holding company for Bajaj Finance and the Bajaj Allianz insurance businesses. At Rs 1,845, the stock has a market capitalisation of Rs 2,65,782 crore and trades at 12.88 times earnings, while the industry P/E is 16.13.

Reported numbers show FY26 revenue of Rs 1,50,530 crore, up 13.2% year on year, with net profit at Rs 19,669 crore, up 12.0%. The June 2026 quarter added revenue of Rs 42,037 crore (up 19.1%) and net profit of Rs 6,297 crore (up 18.2%).

Return on equity is 12.58%, and the dividend yield is 0.09%. Promoters hold 58.65%, foreign institutions 8.16% and domestic institutions 11.10% as of September 2026.

Check Under Rs 2060 Stocks Live on the Univest Screener

Cholamandalam Investment and Finance: The Vehicle Finance Specialist Among Under Rs 2060 Stocks to Buy

Cholamandalam Investment and Finance is a vehicle finance, home loan and small business lender in the Murugappa Group. Its market capitalisation is Rs 1,37,140 crore, the share price is Rs 1,815 and the P/E of 22.04 compares with an industry P/E of 16.15.

Over FY26, net profit rose 22.7% to Rs 5,229 crore on revenue of Rs 31,539 crore, which was up 20.6%. The latest quarter, the September 2026 quarter, brought revenue of Rs 9,395 crore, up 23.4% year on year, and net profit of Rs 1,630 crore, up 40.6%.

Return on equity is 18.02%, and the dividend yield is 0.12%. Promoters hold 48.93%, foreign institutions 24.87% and domestic institutions 20.38% as of September 2026. Domestic institutional holding has risen from 17.27% to 20.38% over the last year.

Coforge: The Mid-Cap Growth Story Among Under Rs 2060 Stocks to Buy

Coforge is a digital engineering and IT services company serving travel, banking and insurance clients. The stock trades at Rs 2,018 with a market capitalisation of Rs 86,836 crore and a P/E of 41.36, against an industry P/E of 18.92.

FY26 revenue rose 34.6% to Rs 16,476 crore and net profit rose 73.8% to Rs 1,674 crore. In the September 2026 quarter, revenue grew 53.8% year on year to Rs 6,195 crore, while net profit grew 42.2% to Rs 605 crore.

Return on equity is 9.80%, debt-to-equity is 0.27, and the dividend yield is 0.61%. The company has no identified promoter, with foreign institutions holding 24.76% and domestic institutions 43.78% as of September 2026.

Sun Pharmaceutical Industries: The Pharma Heavyweight Among Under Rs 2060 Stocks to Buy

Sun Pharmaceutical Industries is India's largest pharmaceutical company by market value, with a strong domestic franchise and a growing specialty portfolio in the US. At Rs 1,902, the stock has a market capitalisation of Rs 4,22,991 crore and trades at 34.91 times earnings, while the industry P/E is 37.65.

Reported numbers show FY26 revenue of Rs 61,674 crore, up 12.7% year on year, with net profit at Rs 11,565 crore, up 5.3%. The June 2026 quarter added revenue of Rs 16,024 crore (up 11.9%) and net profit of Rs 2,911 crore (up 26.4%).

Return on equity is 13.74%, debt-to-equity is 0.06, and the dividend yield is 0.91%. Promoters hold 52.68%, foreign institutions 14.36% and domestic institutions 22.27% as of September 2026. Domestic institutional holding has risen from 20.23% to 22.27% over the last year.

Download the Univest iOS App or Univest Android App to track these under Rs 2060 stocks live and get daily stock recommendations.

Growth Snapshot: Latest Full Year and Latest Quarter

The table compares year-on-year growth in revenue and net profit for all five under Rs 2060 stocks, using filed results.

Company	Full-Year Revenue Growth	Full-Year Profit Growth	Latest Quarter	Quarter Revenue Growth	Quarter Profit Growth
Avalon Technologies	46.3%	78.0%	Jun 2026	49.9%	145.4%
Bajaj Finserv	13.2%	12.0%	Jun 2026	19.1%	18.2%
Cholamandalam Investment and Finance	20.6%	22.7%	Sep 2026	23.4%	40.6%
Coforge	34.6%	73.8%	Sep 2026	53.8%	42.2%
Sun Pharmaceutical Industries	12.7%	5.3%	Jun 2026	11.9%	26.4%

Factors That Move Under Rs 2060 Stocks to Buy

Four factors tend to drive under Rs 2060 stocks, and each one is worth checking before a purchase.

• Earnings growth: Profit should be rising.
• Sector mix: Electronics, financial services, lending, IT and pharma differ.
• Dividends: Sun Pharmaceutical Industries yields about 0.9%.
• Valuation: P/E runs from about 13 to 103.

Risks to Keep in Mind Before Buying Under Rs 2060 Stocks

The first risk is that a higher share price says little about value, so earnings and valuation matter more. The second is that Avalon Technologies trades at a P/E near 103 while Bajaj Finserv trades near 13, and Cholamandalam Investment and Finance carries the highest borrowings of the five as a lender. Check results every quarter.

On the numbers, Avalon Technologies trades at the highest P/E on this list at 102.66, so its earnings need to keep growing to support the price. Under Rs 2060 stocks to buy can still fall when markets turn weak, and a staggered entry has historically suited investors better than a lump-sum purchase.

How to Choose Under Rs 2060 Stocks to Buy

• Look at earnings: Price alone is not a signal.
• Check P/E: Bajaj Finserv trades lowest.
• Read ROE: Cholamandalam Investment and Finance leads.
• Diversify: Spread across the five sectors.

How to Invest in Under Rs 2060 Stocks

1. Shortlist two or three companies from this list that match your risk appetite.
2. Open the Univest Screener and compare P/E, ROE and debt for each stock.
3. Check the latest quarterly results and shareholding pattern on NSE or BSE.
4. Decide an amount you can hold for three to five years and split it into two or three purchases.
5. Review the holding after every quarterly result instead of reacting to daily price moves.

Conclusion

Bajaj Finserv offers the lowest P/E on this list at 12.88, Cholamandalam Investment and Finance has the highest return on equity at 18.02%, and Avalon Technologies posted the fastest net profit growth in its latest full year at 78.0%. Among the best under Rs 2060 stocks in India, these five give investors a spread of size, valuation and growth, so the right pick depends on risk appetite and holding period. Spread the entry, keep position sizes sensible and consult a SEBI-registered advisor before investing in any of these under Rs 2060 stocks to buy.

Frequently Asked Questions on Under Rs 2060 Stocks to Buy

Which are the best under Rs 2060 stocks to buy in November 2026?

Ans. The five under Rs 2060 stocks on the November 2026 watchlist are Avalon Technologies, Bajaj Finserv, Cholamandalam Investment and Finance, Coforge and Sun Pharmaceutical Industries. Bajaj Finserv has the lowest P/E at 12.88, Cholamandalam Investment and Finance has the highest ROE at 18.02%, and Avalon Technologies grew net profit 78.0% in its latest full year. This is educational content, not investment advice, so please consult a SEBI-registered advisor.

Is Sun Pharmaceutical Industries a good stock to buy from this Under Rs 2060 list?

Ans. Sun Pharmaceutical Industries is the largest company on this list with a market capitalisation of Rs 4,22,991 crore and a P/E of 34.91 against an industry P/E of 37.65. Its FY26 revenue rose 12.7% and net profit rose 5.3%, with return on equity at 13.74%. Whether it suits you depends on your risk appetite and holding period, so please consult a SEBI-registered advisor before investing.

Are these under Rs 2060 stocks expensive right now?

Ans. Valuations vary across the group. Avalon Technologies trades at a P/E of 102.66, Bajaj Finserv trades at a P/E of 12.88, Cholamandalam Investment and Finance trades at a P/E of 22.04, Coforge trades at a P/E of 41.36, Sun Pharmaceutical Industries trades at a P/E of 34.91, against industry multiples ranging from 16.13 to 41.86. Higher multiples reflect faster growth but also leave less room for earnings misses, so entry price deserves attention.

Which of these under Rs 2060 stocks pay a dividend?

Ans. Dividend yields on this list are Bajaj Finserv 0.09%, Cholamandalam Investment and Finance 0.12%, Coforge 0.61%, Sun Pharmaceutical Industries 0.91%. Yields are modest across the group, so most investors look at these stocks for growth in earnings rather than for income, and payouts can change with company profits.

Which stock on this list has the highest return on equity?

Ans. Cholamandalam Investment and Finance has the highest ROE on this list at 18.02%, followed by Avalon Technologies at 15.65% and Sun Pharmaceutical Industries at 13.74%. A higher ROE shows a company earns more profit on shareholder capital, but it should be read alongside valuation and debt.

What are the risks of investing in under Rs 2060 stocks?

Ans. The main risks are price levels that say little about value, one extreme valuation and borrowings at the lenders. On this list, Avalon Technologies trades at the highest P/E of 102.66, which leaves less room for earnings disappointments. Staggered buying and a long holding period can help manage these risks.

How can I invest in under Rs 2060 stocks in India?

Ans. You can buy these stocks directly on NSE or BSE through a demat account, and compare them first on the Univest Screener using P/E, ROE and debt. Many investors split the amount across two or three purchases and review the holding after each quarterly result. Sector-themed mutual funds and ETFs are another route for investors who prefer diversification.